{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:38:25Z","timestamp":1789144705977,"version":"build-2803163510"},"reference-count":142,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,23]],"date-time":"2026-12-23T00:00:00Z","timestamp":1797984000000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["1Z1AAA000375-19"],"award-info":[{"award-number":["1Z1AAA000375-19"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajpath.2025.03.010","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T02:34:16Z","timestamp":1744943656000},"page":"136-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and Beyond"],"prefix":"10.1016","volume":"196","author":[{"given":"Lihong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhan","family":"Yokus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0505-2972","authenticated-orcid":false,"given":"Bin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-8108","authenticated-orcid":false,"given":"Pal","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.03.010_bib1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMra2207599","article-title":"Alcohol-associated hepatitis","volume":"387","author":"Bataller","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40261-022-01143-9","article-title":"Management of alcohol-related liver disease and its complications","volume":"42","author":"Cabezas","year":"2022","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.ajpath.2025.03.010_bib3","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.03.010_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100009","article-title":"Advances in the diagnosis and management of hepatorenal syndrome: insights into HRS-AKI and liver transplantation","volume":"1","author":"Arnold","year":"2023","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib6","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4254\/wjh.v13.i11.1699","article-title":"Hepatopulmonary syndrome: an update","volume":"13","author":"Gandhi","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2025.03.010_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000133","article-title":"Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis","volume":"7","author":"Amonker","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.03.010_bib10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2025.03.010_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2025.03.010_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jcmgh.2022.08.001","article-title":"Sex-dependent hepatoprotective role of IL-22 receptor signaling in non-alcoholic fatty liver disease-related fibrosis","volume":"14","author":"Abdelnabi","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7150\/ijbs.42300","article-title":"Aldehyde dehydrogenase, liver disease and cancer","volume":"16","author":"Wang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2025.03.010_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cld.920","article-title":"Alcohol-associated liver disease: East versus West","volume":"16","author":"Charatcharoenwitthaya","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ajpath.2025.03.010_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.ajpath.2025.03.010_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100013","article-title":"Alcohol-associated bowel disease: new insights into pathogenesis","volume":"1","author":"Maccioni","year":"2023","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib18","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s42255-024-01063-2","article-title":"Coordinated action of a gut-liver pathway drives alcohol detoxification and consumption","volume":"6","author":"Fu","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.ajpath.2025.03.010_bib19","doi-asserted-by":"crossref","first-page":"25974","DOI":"10.1073\/pnas.1908137116","article-title":"Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking","volume":"116","author":"Guillot","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.03.010_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.03.010_bib22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2025.03.010_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86678.2","article-title":"Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitis","volume":"12","author":"Ahmadi","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.ajpath.2025.03.010_bib24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2021.05.041","article-title":"Loss of hepatocyte identity following aberrant YAP activation: a key mechanism in alcoholic hepatitis","volume":"75","author":"Saleh","year":"2021","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib25","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI132691","article-title":"Epithelial splicing regulatory protein 2\u2013mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis","volume":"130","author":"Hyun","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.03.010_bib26","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3748\/wjg.v20.i9.2136","article-title":"Role of mitochondria in alcoholic liver disease","volume":"20","author":"Nassir","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/cells9040837","article-title":"Role and mechanisms of mitophagy in liver diseases","volume":"9","author":"Ma","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2025.03.010_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178616","article-title":"IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis","volume":"134","author":"Guan","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.03.010_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157780","article-title":"Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure","volume":"132","author":"Ma","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.03.010_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/genes14020290","article-title":"DNA double-strand break-related competitive endogenous RNA network of noncoding RNA in bovine cumulus cells","volume":"14","author":"Liu","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ajpath.2025.03.010_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100104","article-title":"Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease","volume":"2","author":"Gao","year":"2024","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib32","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/apt.13164","article-title":"Alcohol and gut microbiota-the possible role of gut microbiota modulation in the treatment of alcoholic liver disease","volume":"41","author":"Vassallo","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2025.03.010_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/mi.2013.109","article-title":"REG3[gamma]-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum","volume":"7","author":"Loonen","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192195","article-title":"The role of IL-22 in intestinal health and disease","volume":"217","author":"Keir","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2022.02.021","article-title":"Development and validation of a model to predict incident chronic liver disease in the general population: the CLivD score","volume":"77","author":"\u00c5berg","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrgastro.2017.116","article-title":"Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations","volume":"15","author":"Parker","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib38","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2468-1253(23)00206-6","article-title":"MetALD: new opportunities to understand the role of alcohol in steatotic liver disease","volume":"8","author":"Israelsen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib39","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.27921","article-title":"Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1","volume":"62","author":"Chang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcmgh.2018.01.003","article-title":"Neutrophil\u2013hepatic stellate cell interactions promote fibrosis in experimental steatohepatitis","volume":"5","author":"Zhou","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3350\/cmh.2020.0100","article-title":"Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: a model of high-fat diet and binge ethanol intake","volume":"26","author":"Hwang","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.31031","article-title":"Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib43","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/jhep.2001.28233","article-title":"The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis","volume":"34","author":"Kuper","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib44","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/HEP.0000000000000890","article-title":"Alcohol-associated liver cancer","volume":"80","author":"Fu","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib45","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.31042","article-title":"Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis","volume":"71","author":"Rogal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13014","article-title":"Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder","volume":"5","author":"Vannier","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpath.2025.03.010_bib47","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.7150\/ijbs.38925","article-title":"Interleukin 22 in liver injury, inflammation and cancer","volume":"16","author":"Wu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2025.03.010_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib50","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat Genetics"},{"key":"10.1016\/j.ajpath.2025.03.010_bib51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jhep.2014.06.006","article-title":"A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease","volume":"61","author":"Nischalke","year":"2014","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0712-x","article-title":"The biology of hepatocellular carcinoma: implications for genomic and immune therapies","volume":"16","author":"Khemlina","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ajpath.2025.03.010_bib53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00281-021-00854-z","article-title":"The good and the bad about separation anxiety: roles of IL-22 and IL-22BP in liver pathologies","volume":"43","author":"L\u00fccke","year":"2021","journal-title":"Semin Immunopathology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib54","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.3390\/cancers14246019","article-title":"A critical role of the IL-22\u2013IL-22 binding protein axis in hepatocellular carcinoma","volume":"14","author":"Giannou","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ajpath.2025.03.010_bib55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2021.10.005","article-title":"A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers","volume":"76","author":"Whitfield","year":"2022","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib57","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2023.5997","article-title":"Diagnosis and management of cirrhosis and its complications: a review","volume":"329","author":"Tapper","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajpath.2025.03.010_bib58","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib60","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib61","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib62","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib63","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41569-020-0433-5","article-title":"Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications","volume":"18","author":"Matyas","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib66","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0168-8278(98)80022-6","article-title":"The sympathetic nervous system in liver disease","volume":"29","author":"Henriksen","year":"1998","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib67","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2019.11.027","article-title":"Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome","volume":"152","author":"Trojnar","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib68","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib69","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib70","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/intimm\/dxr001","article-title":"Recent advances in IL-22 biology","volume":"23","author":"Zenewicz","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.766586","article-title":"IL-22 binding protein (IL-22BP) in the regulation of IL-22 biology","volume":"12","author":"Zenewicz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin immunopathol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22\u2013IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajpath.2025.03.010_bib74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41423-018-0029-8","article-title":"Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects","volume":"16","author":"Tang","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib75","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15619","article-title":"Novel treatment of acute and acute-on-chronic liver failure: interleukin-22","volume":"45","author":"Hwang","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.ajpath.2025.03.010_bib77","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.gastro.2012.03.044","article-title":"Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection","volume":"143","author":"Feng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib78","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib79","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","article-title":"In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression","volume":"54","author":"Park","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2025.03.010_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156293","article-title":"IL-22 as a target for therapeutic intervention: current knowledge on its role in various diseases","volume":"169","author":"Seth","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.ajpath.2025.03.010_bib83","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.autrev.2017.10.004","article-title":"Interleukin-22 in human inflammatory diseases and viral infections","volume":"16","author":"Shabgah","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajpath.2025.03.010_bib84","doi-asserted-by":"crossref","first-page":"F1041","DOI":"10.1152\/ajprenal.00005.2015","article-title":"Interleukin-22 in kidney injury and regeneration","volume":"308","author":"Weidenbusch","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib85","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1681\/ASN.2013050528","article-title":"Toll-like receptor 4\u2013induced IL-22 accelerates kidney regeneration","volume":"25","author":"Kulkarni","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib86","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1681\/ASN.2013060611","article-title":"IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium","volume":"25","author":"Xu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.apsb.2020.07.002","article-title":"VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses","volume":"11","author":"Shen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajpath.2025.03.010_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.292","article-title":"Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2025.03.010_bib89","first-page":"3872","article-title":"Differentiation and recruitment of IL-22-producing helper T cells in lgA nephropathy","volume":"8","author":"Xiao","year":"2016","journal-title":"Am J Translational Res"},{"key":"10.1016\/j.ajpath.2025.03.010_bib90","article-title":"Interleukin-22 from type 3 innate lymphoid cells aggravates lupus nephritis by promoting macrophage infiltration in lupus-prone mice","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cpt.1164","article-title":"Randomized phase I healthy volunteer study of UTTR1147A (IL-22Fc): a potential therapy for epithelial injury","volume":"105","author":"Rothenberg","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2025.03.010_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05382.x","article-title":"An overview of cytokines and cytokine antagonists as therapeutic agents","volume":"1182","author":"Donnelly","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajpath.2025.03.010_bib93","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bcp.2018.03.031","article-title":"Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases","volume":"152","author":"Stefanich","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib94","series-title":"Interleukin-22: a bridge between epithelial innate host defense and immune cells. Cytokine Frontiers: Regulation of Immune Responses in Health and Disease","first-page":"147","author":"Wang","year":"2014"},{"key":"10.1016\/j.ajpath.2025.03.010_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021799","article-title":"IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease","volume":"6","author":"Taube","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.03.010_bib96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib97","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ajpath.2012.12.007","article-title":"IL-22 is essential for lung epithelial repair following influenza infection","volume":"182","author":"Pociask","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib98","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib99","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.03.010_bib100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.20102149","article-title":"Memory\/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22\u2013dependent intestinal pathology","volume":"208","author":"Kamanaka","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib101","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1039\/D3FO04530G","article-title":"Limonin alleviates high-fat diet-induced dyslipidemia by regulating the intestinal barrier via the microbiota-related ILC3\u2013IL22\u2013IL22R pathway","volume":"15","author":"Wu","year":"2024","journal-title":"Food Funct"},{"key":"10.1016\/j.ajpath.2025.03.010_bib102","doi-asserted-by":"crossref","first-page":"C305","DOI":"10.1152\/ajpcell.00005.2017","article-title":"Lipopolysaccharide downregulates macrophage-derived IL-22 to modulate alcohol-induced hepatocyte cell death","volume":"313","author":"Liu","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib103","article-title":"Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.03.010_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/SHK.0b013e3182749f96","article-title":"Interleukin-22 modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury","volume":"39","author":"Rendon","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.ajpath.2025.03.010_bib105","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib106","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/hep4.1303","article-title":"IL-22 and IL-22-binding protein are associated with development of and mortality from acute-on-chronic liver failure","volume":"3","author":"Schwarzkopf","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.03.010_bib107","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/acer.15021","article-title":"Interleukin-22 alleviates alcohol-associated hepatic fibrosis, inhibits autophagy, and suppresses the PI3K\/AKT\/mTOR pathway in mice","volume":"47","author":"Meng","year":"2023","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2025.03.010_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1289356","article-title":"Promoting intestinal antimicrobial defense and microbiome symbiosis contributes to IL-22-mediated protection against alcoholic hepatitis in mice","volume":"14","author":"Yue","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib110","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/acer.15048","article-title":"Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in mice","volume":"47","author":"Kouno","year":"2023","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2025.03.010_bib111","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","article-title":"The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","volume":"178","author":"Sa","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib112","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1016\/j.jmb.2015.10.013","article-title":"Pathogen resistance mediated by IL-22 signaling at the epithelial\u2013microbiota interface","volume":"427","author":"Schreiber","year":"2015","journal-title":"J Molecular Biology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib113","doi-asserted-by":"crossref","first-page":"12650","DOI":"10.1080\/21655979.2022.2070998","article-title":"The amelioration of alcohol-induced liver and intestinal barrier injury by Lactobacillus rhamnosus Gorbach-Goldin (LGG) is dependent on interleukin 22 (IL-22) expression","volume":"13","author":"Ge","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.ajpath.2025.03.010_bib114","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jgh.12032","article-title":"Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease","volume":"28","author":"Kong","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib115","first-page":"5449","article-title":"IL-22 inactivates hepatic stellate cells via downregulation of the TGF-[beta]1\/Notch signaling pathway","volume":"17","author":"Chen","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ajpath.2025.03.010_bib116","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/25785826.2020.1775060","article-title":"Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells","volume":"43","author":"Komine-Aizawa","year":"2020","journal-title":"Immunological Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib117","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jdermsci.2017.12.017","article-title":"Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts","volume":"90","author":"Sawamura","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ajpath.2025.03.010_bib118","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/HEP.0000000000000671","article-title":"AASLD practice guidance on acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis","volume":"79","author":"Karvellas","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib119","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","article-title":"Acute-on-chronic liver failure in patients with alcohol-related liver disease","volume":"70","author":"Gustot","year":"2019","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib120","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J Hepatology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib121","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/JLB.4A0122-068R","article-title":"IL-22 and Lactobacillus delbrueckii mitigate alcohol-induced exacerbation of DSS-induced colitis","volume":"112","author":"Cannon","year":"2022","journal-title":"J Leukocyte Biology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib122","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1271\/bbb.110061","article-title":"Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice","volume":"75","author":"Xing","year":"2011","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.ajpath.2025.03.010_bib123","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gutjnl-2018-317232","article-title":"Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice","volume":"68","author":"Hendrikx","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2025.03.010_bib124","first-page":"43","article-title":"Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3","volume":"1","author":"Pan","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib125","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/nu15092086","article-title":"FGF21 depletion attenuates colitis through intestinal epithelial IL-22-STAT3 activation in mice","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpath.2025.03.010_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1202267","article-title":"One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease","volume":"14","author":"Sagaram","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib127","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13817","article-title":"IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis","volume":"6","author":"Weidenbusch","year":"2018","journal-title":"Physiol Rep"},{"key":"10.1016\/j.ajpath.2025.03.010_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.324","article-title":"IL-22-mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.kint.2023.09.020","article-title":"IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury","volume":"105","author":"Taguchi","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2025.03.010_bib130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1165\/rcmb.2009-0440OC","article-title":"Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury","volume":"44","author":"Hoegl","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/dxv070","article-title":"Innate-like function of memory Th17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22","volume":"28","author":"Sakaguchi","year":"2016","journal-title":"Int Immunology"},{"key":"10.1016\/j.ajpath.2025.03.010_bib132","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1084\/jem.20100061","article-title":"[gamma][delta] T cells protect against lung fibrosis via IL-22","volume":"207","author":"Simonian","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2025.03.010_bib133","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thoraxjnl-2017-211097","article-title":"Facilitation of IL-22 production from innate lymphoid cells by prostaglandin E2 prevents experimental lung neutrophilic inflammation","volume":"73","author":"Felton","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.ajpath.2025.03.010_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1917804","article-title":"JAK2\/STAT3 pathway was associated with the protective effects of IL-22 on aortic dissection with acute lung injury","volume":"2017","author":"Ren","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.ajpath.2025.03.010_bib135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.00550-19","article-title":"Interleukin-22 (IL-22) binding protein constrains IL-22 activity, host defense, and oxidative phosphorylation genes during pneumococcal pneumonia","volume":"87","author":"Trevejo-Nunez","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.ajpath.2025.03.010_bib136","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/mi.2017.15","article-title":"Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection","volume":"10","author":"Treerat","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib137","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajpath.2023.11.011","article-title":"IL-22 binding protein controls IL-22\u2013driven bleomycin-induced lung injury","volume":"194","author":"Zhang","year":"2024","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib138","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.4049\/jimmunol.1201797","article-title":"The [beta]-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22","volume":"189","author":"Lilly","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2025.03.010_bib139","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1182\/blood-2023-181269","article-title":"Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute Gvhd","volume":"142","author":"Satta","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2025.03.010_bib140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10928-023-09888-2","article-title":"Population pharmacokinetics and pharmacodynamics of efmarodocokin alfa (IL-22Fc)","volume":"51","author":"Yu","year":"2024","journal-title":"J Pharmacokinet Pharmacodynamics"},{"key":"10.1016\/j.ajpath.2025.03.010_bib141","doi-asserted-by":"crossref","first-page":"S382","DOI":"10.1093\/ecco-jcc\/jjz203.549","article-title":"P420 A randomised, observer-blinded phase Ib multiple, ascending dose study of UTTR1147A, an IL-22Fc fusion protein, in healthy volunteers and ulcerative colitis patients","volume":"14","author":"Wagner","year":"2020","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.ajpath.2025.03.010_bib142","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12072-020-10082-6","article-title":"Interleukin-22 in alcoholic hepatitis and beyond","volume":"14","author":"Xiang","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ajpath.2025.03.010_bib143","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s42255-024-01063-2","article-title":"Coordinated action of a gut\u2013liver pathway drives alcohol detoxification and consumption","volume":"6","author":"Fu","year":"2024","journal-title":"Nat Metab"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:55:44Z","timestamp":1768935344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0002944025001178"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.03.010","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and Beyond","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}